Calcium carbonate nanoparticles have salient properties, such as biocompatibility, pH responsiveness, and the ability to alkalinize a tumor, thereby reducing metastasis. A combination therapy regimen is normative for breast cancer, and besides its side effects, toxic vehicles are required for certain drugs. This
[...] Read more.
Calcium carbonate nanoparticles have salient properties, such as biocompatibility, pH responsiveness, and the ability to alkalinize a tumor, thereby reducing metastasis. A combination therapy regimen is normative for breast cancer, and besides its side effects, toxic vehicles are required for certain drugs. This study is aimed to transform the readily available Blood cockle shells (
Anadara granosa) to calcium carbonate nanoparticles (CSCaCO
3NP), loading them with Gefitinib (GEF) and Paclitaxel (PTXL). Facile top-down synthesis of CSCaCO
3NP is comprised of grinding, sieving, and stirring with Tween 80, followed by filtration and finally dry milling for 120 h. A ratio of 1 + 0.5:25 of GEF+PTXL: CSCaCO
3NP in an equal admixture of DMSO and 0.05% Tween 80 buffer was used for drug loading. Loading content (%) and encapsulation efficiency (%) for GEF and PTXL in dual drug-loaded NP (GEF-PTXL-CSCaCO
3NP) was 1.98 ± 0.11, 50.01 ± 2.18 and 0.92 ± 0.01, 45.60 ± 0.32. Field emission scanning electron micrographs revealed that the nanoparticles were almost spherical with the average diameter (nm) measuring 63.96 ± 22.3 and 87.20 ± 26.66 for CSCaCO
3NP, and GEF-PTXL-CSCaCO
3NP, respectively. The Dynamic Light Scattering data gives the average diameter of CSCaCO
3NP and GEF-PTXL-CSCaCO
3NP as 179 ± 10.9 (nm), and 274 ± 23.22 (nm), and Zeta potential was −17 ± 1.15 (mV) and −10.30 ± 1.7 (mV), respectively. Fourier-transform Infrared spectroscopy proves that CSCaCO
3NP have been loaded with the drugs. X-Ray Diffraction data indicate that the aragonite phase is unaltered. N
2 adsorption-desorption isotherms reveals that CSCaCO
3NP are mesoporous and that the surface area was reduced from 10.68 ± 0.22 to 9.88 ± 0.24 m
2/g after drug loading. For the first time, this work will describe the process that enabled to synthesize CSCaCO
3NP, which was used as a carrier to load GEF and PTXL and its salient characteristics.
Full article